Core Viewpoint - President Trump is reportedly considering an order to reschedule marijuana from a Schedule I to a Schedule III drug, which could significantly impact the cannabis industry by allowing companies to access banking services and reducing tax burdens [1][2][3] Industry Impact - Rescheduling marijuana would not legalize it but would allow cannabis companies to operate more freely, potentially leading to a different tax status, reducing tax rates from approximately 40% to around 10-15% [3][9] - The cannabis market is currently experiencing volatility, with some stocks, like MISO, seeing increases of up to 38% due to speculation around this potential order [5][13] Regulatory Process - The Department of Justice (DOJ) and the Drug Enforcement Administration (DEA) are expected to restart the rulemaking process for rescheduling, which is about 70% complete and could be finalized by the first half of next year if expedited [6][17] - There is uncertainty regarding the specifics of the order, as it may face legal challenges if it does not provide clear directives for rescheduling [7][9] Market Sentiment - Retail sentiment is currently high in the cannabis market, with Canadian pot equities also seeing increases of around 30%, although this does not directly apply to U.S. companies [13][14] - The potential for consolidation in the cannabis industry is anticipated as regulatory frameworks improve, with larger companies likely to acquire smaller ones [16][18]

President Trump wants to change the regulations on cannabis. Will this change Canopy into a profitable stock?Canopy Growth (CGC +49.56%) stock soared 17% through 12:50 p.m. ET Friday on some positive marijuana news out of the White House.As The Washington Post reports, President Trump aims to reschedule pot in the near future. This is not quite "legalization", but it's apparently enough to get marijuana investors excited today. President Trump's Christmas gift to marijuana investorsThe Post cites six perso ...

A report stating that the Trump administration is close to reclassifying cannabis as a Schedule III drug—on par with mild painkillers—has the $32 billion industry hotly anticipating reform.Read more: https://t.co/cU5i6hGc0DPhoto: Jens Schlueter/AFP via Getty Images https://t.co/iY80nS13ak ...

If weed becomes legal, will Aurora Cannabis become profitable?Aurora Cannabis (ACB +15.38%) stock leapt 14.5% "higher" (get it? Marijuana? High?) through 11:55 a.m. ET Friday on some positive marijuana news out of the White House.As The Washington Post reports, President Trump wants to legalize marijuana (sort of), and marijuana investors are overjoyed at the prospect. President Trump's Christmas gift to marijuana investorsThe Post cites six separate sources confirming that Trump will issue an executive or ...

Cannabis stocks like Tillray, Aurora, and the Advisor Shares ETF are all soaring on these reports that the president will move to reclassify marijuana as a less dangerous drug. Our Brandon Gomez has been covering the story for what feels like forever and has more on the timing of this news. Hey, Brandon. >> Hey, Carl.Yeah, that's right. I feel like we've been here before, right. But with the president wanting to reschedule uh the drug to a new classification, now it is currently scheduled as schedule one.No ...

Cannabis stocks haven't moved like this in years, and it took a rare one-two punch to jolt the sector back to life: a Washington Post scoop hinting that President Donald Trump wants to reclassify marijuana into Schedule III — and a Tilray Brands Inc (NASDAQ:TLRY) vape launch so successful it broke the internal math of the company's own product mix. Track TLRY stock here.For an industry that's spent half a decade stuck in existential purgatory, this is what a revival looks like.Read Also: Tilray, Canopy And ...

Cannabis stocks haven't moved like this in years, and it took a rare one-two punch to jolt the sector back to life: a Washington Post scoop hinting that President Donald Trump wants to reclassify marijuana into Schedule III — and a Tilray Brands Inc (NASDAQ:TLRY) vape launch so successful it broke the internal math of the company's own product mix. Track TLRY stock here.For an industry that's spent half a decade stuck in existential purgatory, this is what a revival looks like.Read Also: Tilray, Canopy And ...

Core Insights - Tilray Brands Inc (NASDAQ:TLRY) stock has surged by 29% to $10.87 following reports that U.S. President Donald Trump intends to reclassify marijuana and ease restrictions significantly [1] - The stock is trading at its highest levels since mid-November, breaking above the descending 20-day moving average, and could mark its largest daily percentage gain since a 60.9% increase in September [1] Options Activity - Options trading for Tilray has seen a significant uptick, with 49,000 calls and 18,000 puts exchanged, which is six times the typical volume for this time [2] - The most popular options include the weekly 12/12 11-strike put and the 12-strike call, with new positions being opened in both [2] Short Interest - Short interest in Tilray has decreased by 88.8% over the last two weeks, although it still represents 9.6% of the stock's available float [3] - It would take nearly two days for short sellers to cover their positions based on TLRY's average trading volume [3]

Jacob Green / iStock via Getty Images This article will be updated throughout the day, so check back often for more daily updates. The Vanguard S&P 500 ETF (NYSEMKT: VOO) ended up gaining a modest 0.25% on Thursday, one day after the Federal Reserve cut interest rates by the expected... 0.25%. Just a coincidence, I'm sure. And it's a coincidence, too, that with zero interest rate cuts remaining in 2025, the Voo is exactly flat premarket today. That doesn't mean there's no news to report, however. The ...

420 Investor launched in 2013, just ahead of Colorado legalizing for adult-use. We have moved the service to Seeking Alpha. Historically, we have provided great coverage of the sector with model portfolios, videos, and written material to help investors learn about cannabis stocks, and we are excited to be doing it here!Alan Brochstein, CFA, is one of the first investment professionals to focus exclusively on the cannabis industry. Alan got his start as a financial professional in the securities industry in ...